SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $701,000 | +19.0% | 3,582 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $589,000 | +25.9% | 3,582 | -11.7% | 0.00% | 0.0% |
| Q1 2020 | $468,000 | -1.5% | 4,057 | -2.3% | 0.00% | – |
| Q4 2019 | $475,000 | +48.9% | 4,153 | -1.1% | 0.00% | – |
| Q3 2019 | $319,000 | +11.9% | 4,200 | +1.9% | 0.00% | – |
| Q2 2019 | $285,000 | -5.9% | 4,121 | -0.2% | 0.00% | – |
| Q1 2019 | $303,000 | +30.0% | 4,131 | +0.5% | 0.00% | – |
| Q4 2018 | $233,000 | -26.5% | 4,110 | +0.1% | 0.00% | – |
| Q3 2018 | $317,000 | +2.3% | 4,106 | -11.9% | 0.00% | – |
| Q2 2018 | $310,000 | +27.0% | 4,663 | 0.0% | 0.00% | – |
| Q1 2018 | $244,000 | -6.2% | 4,663 | -4.1% | 0.00% | – |
| Q4 2017 | $260,000 | -3.7% | 4,860 | -2.2% | 0.00% | – |
| Q3 2017 | $270,000 | +8.0% | 4,970 | +3.0% | 0.00% | – |
| Q2 2017 | $250,000 | -12.0% | 4,824 | +6.6% | 0.00% | – |
| Q1 2017 | $284,000 | +18.3% | 4,525 | -0.7% | 0.00% | – |
| Q4 2016 | $240,000 | +12.1% | 4,555 | +14.8% | 0.00% | – |
| Q3 2016 | $214,000 | +44.6% | 3,967 | +8.7% | 0.00% | – |
| Q2 2016 | $148,000 | +19.4% | 3,651 | -0.7% | 0.00% | – |
| Q1 2016 | $124,000 | -23.5% | 3,677 | +2.0% | 0.00% | – |
| Q4 2015 | $162,000 | +16.5% | 3,605 | 0.0% | 0.00% | – |
| Q3 2015 | $139,000 | -21.0% | 3,605 | -0.7% | 0.00% | – |
| Q2 2015 | $176,000 | +46.7% | 3,629 | +6.6% | 0.00% | – |
| Q1 2015 | $120,000 | +10.1% | 3,405 | 0.0% | 0.00% | – |
| Q4 2014 | $109,000 | -18.0% | 3,405 | -4.6% | 0.00% | – |
| Q3 2014 | $133,000 | -3.6% | 3,571 | -0.9% | 0.00% | – |
| Q2 2014 | $138,000 | -16.9% | 3,603 | -1.3% | 0.00% | – |
| Q1 2014 | $166,000 | +13.7% | 3,650 | 0.0% | 0.00% | – |
| Q4 2013 | $146,000 | -59.0% | 3,650 | -55.0% | 0.00% | -100.0% |
| Q3 2013 | $356,000 | +8.5% | 8,113 | -22.1% | 0.00% | 0.0% |
| Q2 2013 | $328,000 | – | 10,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |